Pharmaceutical Packaging Market (By Product: Tertiary Pharmaceutical Packaging, Secondary Pharmaceutical Packaging, and Primary Pharmaceutical Packaging; By Material: Paper & Paperboard, Plastics & Polymers, Glass, Aluminum Foil, and Others; By End-use: Retail Pharmacy, Pharmaceutical Manufacturing, Institutional Pharmacy, Contract Packaging, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030

The global pharmaceutical packaging market size was valued at USD 118.05 billion in 2021 and expected to hit USD 244.12 billion by 2030, with at a compound annual growth rate (CAGR) of 8.6% during the forecast period 2022 to 2030..

Growth Factors:

Growing penetration of retail pharmacies in developing regions and a rising focus on brand enhancement and product differentiation by pharmaceutical manufacturers are anticipated to fuel the market growth. Packaging products are primarily utilized for storing solid, liquid, and semisolid forms of formulations, such as tablets, capsules, syrups, and topical drug formulations. The increasing prevalence of chronic diseases due to changing lifestyles, eating habits, and alternation in sleep cycles are contributing to an increased need for medications.

In addition, the focus of various governments on strengthening healthcare facilities and insurance coverage is further expanding the demand for pharmaceuticals, which, in turn, is boosting the market growth. Drugs are majorly offered in pills, liquid, and powder forms. Various packaging types including rigid bottles, standup pouches, flat pouches, sachets, and blister packs are used for their packaging. Pharma packaging products are highly customized products and are bounded by strict regulatory compliances, especially concerning the sterility of the packaging. Thus, the packaging and pharmaceutical product manufacturers work closely during the development of packaging products.

The emergence of counterfeiting activities has led to the imposition of bans on such counterfeit products that can cause undesirable effects on consumers, leading to major health concerns. From February 2019, under the Commission Delegated Regulation (EU) 2016/161, drug makers are required to add a unique identifier and an anti-tampering device to the packaging of most centrally authorized pharmaceutical products. Packaging companies are increasingly focusing on the incorporation of tamper-evident properties into the packaging to enhance their functionality and safety to comply with strict regulations.

Report Scope of the Pharmaceutical Packaging Market

Report Highlights

Details

Market Size

USD 244.12 Billion by 2030

Growth Rate

CAGR of 8.6% From 2022 to 2030

Base Year

2021

Historic Data

2017 to 2020

Forecast Period

2022 to 2030

Segments Covered

Product, Application, Material

Regional Scope

North America, APAC, Europe, Latin America, MEAN, Rest of the World

Companies Mentioned

Becton, Dickinson and Company, Amcor Plc, AptarGroup, Inc., Gerresheimer AG, Drug Plastics Group, Schott AG, West Pharmaceutical Services Inc., Owens Illinois Inc., Berry Global, Inc, SGD S.A., WestRock Company

 Product Insights

Primary pharmaceutical packaging product segment captured the maximum value share of nearly 75% and projected to retain its position over the analysis period. Product advantages that include quality assurance, prevention from contamination, safety during transportation, and enhanced performance are the major factors that anticipated to propel the product demand over the upcoming period.

The primary packaging product segment has been further classified into medication tubes, caps &closures, plastic bottles, blister packs, parenteral containers, pouches, prefillable inhalers, and others. Plastic bottles are the widely used product for packaging various types of medicines and thus emerged as the leader in the primary packaging products.

The secondary product segment projected to witness a CAGR of approximately 7.5% over the forecast period. The secondary packaging refers to a consecutive covering or package that are mostly used for the grouping of pharmaceutical packages. They are largely used for logistics and transportation along with display and branding purposes. This type of packaging is used for protecting drugs as well as the primary packaging.

Application Insights

In 2019, pharmaceutical manufacturing held the largest revenue share of around 36% and projected to maintain the same trend over the forthcoming years. Increasing demand for better medical facilities along with rising population projected to impact positively on the market growth. In addition, favorable government initiatives supporting the development of healthcare industry mostly in the developing countries estimated to boost the segment growth over the analysis period.

Drug or medicine manufacturers are significantly outsourcing the pharmaceutical packaging activities for saving their expenses and time both. Increasing preference for outsourcing service rather than investing on the establishment of packaging infrastructure projected to propel the growth of contract packaging segment during the upcoming years.

Regional Insights

North America dominated the market with a revenue share of over 35.2% in 2021. Pharma manufacturing, which includes in-house production, was the largest end-use segment in the region in 2021. The 21st Century Cures Act (Cures Act) was signed on December 13, 2016, in the U.S. to accelerate medical product development. The law is expected to drive product innovations in the pharmaceutical industry, which, in turn, will drive the demand for pharmaceutical packaging in North America.

Asia Pacific is expected to register the fastest CAGR of 13.9% from 2022 to 2030. Growing health awareness among consumers in Asia Pacific, especially in developing countries including China and India, coupled with the rising disposable income levels, is anticipated to boost the growth of the pharmaceutical industry over the forecast period. This is expected to augment the demand for pharmaceutical packaging. China dominated the Asia Pacific market in 2021 and will retain the leading position over the coming years owing to increasing government initiatives, such as Healthy China 2020, growing contract-manufacturing activities, and burgeoning aging population.

Europe is expected to witness considerable growth over the forecast period owing to the rising research & development activities and the introduction of new medicines aimed at improving patient health and their quality of life. Companies such as BioNTech SE and CureVac in Europe have proven success in their vaccines in 2020, which has been further attracting investments in the biotech industry in countries, such as Germany, Russia, and the U.K

Some of the prominent players in the Pharmaceutical Packaging Market include:

  • Becton, Dickinson and Company
  • Amcor Plc
  • AptarGroup, Inc.
  • Gerresheimer AG
  • Drug Plastics Group
  • Schott AG
  • West Pharmaceutical Services Inc.
  • Owens Illinois Inc.
  • Berry Global, Inc
  • SGD S.A.
  • WestRock Company
  • International Paper Company
  • CCL Industries Inc.
  • COMAR LLC
  • Vetter Pharma International

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

By Product

  • Tertiary Pharmaceutical Packaging
  • Secondary Pharmaceutical Packaging
    • Pharmaceutical Packaging Accessories
    • Prescription Containers
  • Primary Pharmaceutical Packaging
    • Caps & Closures
    • Plastic Bottles
    • Parenteral Containers
    • Prefillable Inhalers
    • Blister Packs
    • Medication Tubes
    • Pouches
    • Others

By Material

  • Paper & Paperboard
  • Plastics & Polymers
    • Polyethylene (PE)
    • Polypropylene (PP)
    • Polyethylene Terephthalate (PET)
    • Polystyrene (PS)
    • Polyvinyl Chloride (PVC)
    • Others
  • Glass
  • Aluminum Foil
  • Others

By Application

  • Retail Pharmacy
  • Pharmaceutical Manufacturing
  • Institutional Pharmacy
  • Contract Packaging
  • Others

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Points Covered in Pharmaceutical Packaging Market Study:

  • Growth of Pharmaceutical Packaging in 2022
  • Market Estimates and Forecasts (2017-2030)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Pharmaceutical Packaging and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Pharmaceutical Packaging Consumption Analysis
  •  Pharmaceutical Packaging Production Analysis
  •  Pharmaceutical Packaging and Management

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Pharmaceutical Packaging Market, By Product

7.1. Pharmaceutical Packaging Market, by Product Type, 2021-2030
7.1.1. Tertiary Pharmaceutical Packaging
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Secondary Pharmaceutical Packaging
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Primary Pharmaceutical Packaging
7.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Pharmaceutical Packaging Market, By Application

8.1. Pharmaceutical Packaging Market, by Application, 2021-2030
8.1.1. Retail Pharmacy
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Pharmaceutical Manufacturing
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Institutional Pharmacy
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Contract Packaging
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Pharmaceutical Packaging Market, By Material

9.1. Pharmaceutical Packaging Market, by Material, 2021-2030
9.1.1. Paper & Paperboard
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Plastics & Polymers
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Glass
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Aluminum Foil
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Pharmaceutical Packaging Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. Market Revenue and Forecast, by Material (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4.3. Market Revenue and Forecast, by Material (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.5.3. Market Revenue and Forecast, by Material (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. Market Revenue and Forecast, by Material (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4.3. Market Revenue and Forecast, by Material (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5.3. Market Revenue and Forecast, by Material (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6.3. Market Revenue and Forecast, by Material (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.7.3. Market Revenue and Forecast, by Material (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. Market Revenue and Forecast, by Material (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4.3. Market Revenue and Forecast, by Material (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5.3. Market Revenue and Forecast, by Material (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6.3. Market Revenue and Forecast, by Material (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.7.3. Market Revenue and Forecast, by Material (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. Market Revenue and Forecast, by Material (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4.3. Market Revenue and Forecast, by Material (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5.3. Market Revenue and Forecast, by Material (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6.3. Market Revenue and Forecast, by Material (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.7.3. Market Revenue and Forecast, by Material (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Market Revenue and Forecast, by Material (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4.3. Market Revenue and Forecast, by Material (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.5.3. Market Revenue and Forecast, by Material (2019-2030)

Chapter 11. Company Profiles

11.1. Becton, Dickinson and Company
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Amcor Plc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. AptarGroup, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Gerresheimer AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Drug Plastics Group
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Schott AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. West Pharmaceutical Services Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Owens Illinois Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Berry Global, Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. SGD S.A.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. WestRock Company
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. International Paper Company
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. CCL Industries Inc.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. COMAR LLC
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Vetter Pharma International
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-img Cross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers